Anti-GD2/4-1BB chimeric antigen receptor T cell therapy for the treatment of Chinese melanoma patients

Table 1 GD2 expression in melanoma

Melanoma subtypes	Number of cases	Number of cases with GD2 expression
Acral	134	67 (50.0)
Mucosal	71	40 (56.3)
CSD	14	2 (14.3)
Non-CSD	27	9 (33.3)
Unknown primary	42	24 (57.1)
Total	288	142 (49.3)

CSD melanomas on skin with chronic sun-induced damage, non-CSD melanomas on skin without chronic sun-induced damage

ISSN: 1756-8722